Gland FDA Thursday, February 6, 2025 +0.20 Positive

FDA Approves EPINEPHRINE — Gland Pharma Limited

Gland Pharma Limited announced on Wednesday the FDA approval of its epinephrine injection for intramuscular use, API ANDA219239. This authorization expands the competitive landscape for emergency allergy treatments, likely pressuring market prices as multiple generic manufacturers vie for commercial share.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed